Open AccessMultiplex PCR-based newborn screening for severe T and B-cell lymphopenia: The first pilot study in Turkey
Author(s) -
Seyhan Kutlug,
Medine Karadag Alpaslan,
Gonca Hancioglu,
Sariye Elif Ozyazici Ozkan,
Didem Cemile Yesilirmak,
Hasan Bulut,
Canan Aygün,
Gonul Ogur,
Alişan Yıldıran
Publication year - 2020
Publication title -
sisli etfal hastanesi tip bulteni / the medical bulletin of sisli hospital
Language(s) - English
Resource type - Journals
eISSN - 1308-5123
pISSN - 1302-7123
DOI - 10.14744/semb.2020.09623
Subject(s) - newborn screening , severe combined immunodeficiency , medicine , dried blood , multiplex , multiplex polymerase chain reaction , incidence (geometry) , immunology , pediatrics , polymerase chain reaction , biology , genetics , gene , chemistry , physics , chromatography , optics
Severe combined immunodeficiency disease (SCID), non-SCID T-cell lymphopenia, and other primary immunodeficiency diseases with T-cell and B-cell lymphopenia have low the T-cell-receptor-excision circles (TRECs) and κ-deleting-recombination-excision circles (KRECs) levels that can be measured in dried blood spots (DBS) of the newborn. The incidence of SCID and non-SCID T-cell lymphopenia in Western societies has been reported by TREC screening of newborns as 1: 58,000 and 1: 7300, respectively. Since there is no similar study in our country, we aimed to perform the first pilot study of TREC and KREC screening of newborn for SCID and non-SCID T-cell lymphopenia in Turkey.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom